Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,700.00
+70.00 (1.51%)
At close: Mar 6, 2026
-25.28%
Market Cap 58.29B
Revenue (ttm) 117.19B
Net Income (ttm) 5.51B
Shares Out 12.91M
EPS (ttm) 465.19
PE Ratio 9.71
Forward PE n/a
Dividend 150.00 (3.19%)
Ex-Dividend Date Dec 29, 2025
Volume 46,000
Average Volume 63,047
Open 4,580.00
Previous Close 4,630.00
Day's Range 4,555.00 - 4,755.00
52-Week Range 4,350.00 - 6,890.00
Beta 0.23
RSI 40.22
Earnings Date n/a

About Jin Yang Pharmaceutical

Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers crivix tablets, Eszol tablets, atolan tablets, prescription drugs, and over-the-counter drugs. It also offers antilipidemic, antiplatelet, gastrointestinal, and respiratory agents; antithrombotics; NSAIDs; menopause symptoms treatment; and stomatological products. The company also exports its products. Jin Yang Pharmaceutical Co., Ltd. was founded in 1971 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1971
Employees 220
Stock Exchange KOSDAQ
Ticker Symbol 007370
Full Company Profile

Financial Performance

In 2024, Jin Yang Pharmaceutical's revenue was 113.33 billion, an increase of 20.94% compared to the previous year's 93.71 billion. Earnings were 29.69 billion, an increase of 140.63%.

Financial Statements

News

There is no news available yet.